← Back to Search

Peripheral Nerve Stimulation

Peripheral Nerve Stimulation for Shoulder Impingement Syndrome

N/A
Waitlist Available
Led By Richard D Wilson, MD
Research Sponsored by MetroHealth Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Worst pain in the last week>=4 (0-10 scale)
Shoulder pain of >3 months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up prior 7-days] ; baseline (week 1), end of treatment(week 5), 12 weeks post treatment, 24 weeks post treatment
Awards & highlights

Study Summary

This trial will test a new pain relief method for those with shoulder pain caused by subacromial impingement syndrome.

Who is the study for?
This trial is for adults over 21 with chronic shoulder pain from subacromial impingement syndrome lasting more than 3 months, and a pain level of at least 4 out of 10. Participants must be able to care for their skin and manage dressing changes, with stable use of pain medication. Excluded are those with severe trauma to the shoulder, bleeding disorders, compromised immune systems, pregnancy, allergies to tape or adhesives, certain metal implants or conditions that prevent MRI scans.Check my eligibility
What is being tested?
The study tests two types of peripheral nerve stimulation (PNS) against standard physical therapy in treating chronic shoulder pain due to SIS. One PNS type induces muscle contractions while the other does not. The effectiveness of these novel treatments will be compared to see which provides better relief from persistent shoulder discomfort.See study design
What are the potential side effects?
Potential side effects may include skin irritation at the site where devices are attached or implanted for PNS treatment. There could also be temporary increased pain during initial treatment phases as muscles respond to stimulation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My worst pain in the last week was 4 or more on a scale of 0 to 10.
Select...
I have had shoulder pain for more than 3 months.
Select...
I am 21 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~prior 7-days] ; baseline (week 1), end of treatment(week 5), 12 weeks post treatment, 24 weeks post treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and prior 7-days] ; baseline (week 1), end of treatment(week 5), 12 weeks post treatment, 24 weeks post treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in - Short Form (SF) question 3 (BPI-SF3)
Secondary outcome measures
Change Mechanical Quantitative Sensory Testing (QST)
Change in Activities of Daily Living (ADL) performance -Shoulder Pain and Disability Index (SPADI)
Change in Activities of Daily Living(ADL( capacity - Functional Impairment Test-Hand and Neck/Shoulder/Arm (FIT-HaNSA)
+2 more
Other outcome measures
Occurrence of Adverse events

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Contraction Producing Peripheral Nerve StimulationExperimental Treatment2 Interventions
This group will receive: 1) muscle contraction producing peripheral nerve stimulation treatment (which will produce muscle contraction) for three weeks (6 hours daily); and, 2) physical therapy.
Group II: Non Contracting Producing Peripheral Nerve StimulationActive Control2 Interventions
This group will receive: 1) non contraction producing peripheral nerve stimulation treatment (which will not produce muscle contraction) for three weeks (6 hours daily); and, 2) physical therapy.

Find a Location

Who is running the clinical trial?

MetroHealth Medical CenterLead Sponsor
114 Previous Clinical Trials
21,347 Total Patients Enrolled
5 Trials studying Shoulder Pain
410 Patients Enrolled for Shoulder Pain
University of TexasOTHER
187 Previous Clinical Trials
142,385 Total Patients Enrolled
Richard D Wilson, MDPrincipal InvestigatorMetroHealth Medical Center
2 Previous Clinical Trials
155 Total Patients Enrolled
2 Trials studying Shoulder Pain
155 Patients Enrolled for Shoulder Pain

Media Library

Peripheral Nerve Stimulation (Peripheral Nerve Stimulation) Clinical Trial Eligibility Overview. Trial Name: NCT03752619 — N/A
Shoulder Pain Research Study Groups: Non Contracting Producing Peripheral Nerve Stimulation, Contraction Producing Peripheral Nerve Stimulation
Shoulder Pain Clinical Trial 2023: Peripheral Nerve Stimulation Highlights & Side Effects. Trial Name: NCT03752619 — N/A
Peripheral Nerve Stimulation (Peripheral Nerve Stimulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03752619 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals is this research project accepting as participants?

"Affirmative. The clinical trial information available on clinicaltrials.gov reveals that this study, which was initially posted in March of 2019, is still actively recruiting participants. 116 patients need to be sourced from two different research sites."

Answered by AI

Are there any new opportunities to participate in this research?

"Absolutely. According to the information on clinicaltrials.gov, this medical trial is presently enrolling applicants and has been doing so since March 1st 2019 when it was initially posted. As of October 27th 2022, 116 patients are needed from two different sites for successful completion of the experiment."

Answered by AI

Does this research accept elderly participants?

"This study has an age range from 21 to 100; any individuals outside of this bracket are ineligible for participation."

Answered by AI

Who is able to submit applications for this research study?

"In this clinical trial, 116 people aged 21-100 are being enrolled who suffer from shoulder pain that has lasted for a minimum of 3 months. To be considered eligible, candidates must have reported 4 or higher on the 0-10 scale when asked to rate their worst pain in the past week and demonstrate either independent ability or support for managing skin care and dressing changes as well as stable analgesic intake (no more than one opioid/nonopioid)."

Answered by AI

Who else is applying?

What state do they live in?
Ohio
What site did they apply to?
MetroHealth Medical Center
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

I’ve had shoulder pain since January or February of 2023. Have been going to physio therapy since that time, have been referred to a specialist, and have also received a steroid shot in my shoulder but have not seen any improvement. Through an mri, my Dr believes that this is shoulder impingement. I previously did not qualify for the study, but perhaps do now.
PatientReceived 2+ prior treatments
Recent research and studies
~5 spots leftby Aug 2024